Responsible for Roche's Women's Health Portfolio in Malaysia.

Development Science Business Manager responsible for cross-functional strategy and initiatives. Co-lead for Genentech R&D Digital Health, Development Science New Modality (ASO, Gene Therapy), and Patient Centric Testing Strategy. Received approval of $5M investment in <6 months. Chief of staff for Clinical Pharmacology.

• Lead for sourcing for Fitbit Flow Emergency Ventilator device. Enabled team to achieve 3-month design to production readiness schedule• Responsible for strategic sourcing and partnerships for $100MM+ per year spend across display, battery, and power management. Achieved $15+MM annual cost savings• Designed and deployed supplier selection and bidding (RFQ) process resulting in competitive costs while pioneering supplier contracts and cost breakdown transparency for Fitbit• Received endorsement from EVP Operations and leadership for sourcing and partnership strategy• Identified and developed key suppliers through cross-functional collaboration with engineering, product, quality, and manufacturing teams. Facilitated bi-annual business review and commercial roadmap alignment

• Created and managed end-to-end supply chain for Fitbit’s 2020 flagship product• Ensured supply chain alignment with industrial design, commodity management, supplier quality, and product development teams to develop key milestones and ensure program schedule adherence• Managed $20MM+ in supplier capital expenditure required for mass production tooling capacity• Conducted workshop to establish initiatives, standardizing processes and tools across supply chain department

• Advised biotechnology and medical device clients on operations strategy with coordination from corporate strategy, manufacturing, quality, finance, tax, and procurement teams• Architect for external supplier management in biotechnology firm. Defined supplier selection and approval, risk, and quality metrics. Facilitated multi-day workshops sessions to review current processes, identify gaps/opportunities, and develop improved business processes• Conducted M&A diligence including network capacity consolidation and operating efficiency opportunities• Developed and presented network strategy for $1B+ cell and gene therapy company including market analysis, current capacity assessment, and capacity expansion requirements and opportunities

• Tuck Admissions Associate conducting over 80 interviews with prospective MBAs• Teacher Assistant for Decision Sciences (Spreadsheet Modeling) and Statistics• Tuck Bridge Associate coaching and teaching business concepts to undergraduates

Responsible for finishing manufacturing operations including 100% visual inspection of lyophilized final drug product, container closure integrity testing, automated assembly of reconstitution device, and final packaging with serialization

Rotation 3: Packaging Supervisor• Supervised 15 direct reports responsible for the day-to-day production, scheduling, staffing, and material management of clinical and commercial RECOMBINATE, HEMOFIL-M, and RIXUBIS.• Successfully coordinated packaging activities for RIXUBIS, Baxter’s first commercial launch in 10 years• Conceived and implemented “music on the floor” initiative to increase team morale by successfully negotiating through apprehension of Quality and Packaging ManagementRotation 2: Cell Culture Supervisor• Conceptualized and launched buffer/media expansion project to alleviate capacity bottleneck and proactively prepare for an 100% increase in production requirements to support clinical demand • Successfully secured $20,000 in funding from Senior Leadership to pilot novel disposable mixing technology as creative solution for facility capacity constraints• Managed seven direct reports responsible for manufacturing of bulk drug substance for clinical and commercial pipelineRotation 1: Validation Engineer and Project Lead• Managed $300,000 budget and cross-functional team to implement a near infrared device for raw material identification • Creatively re-scoped raw material inspection project resulting in $225,000 savings/year and 55% work reduction while retaining project timeline

Self-taught Perl programming language to analyze big data resulting in 10% improvement in protein identification rate

Instructed a class of 30 students through basic laboratory physics laboratory experiments